This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Comment: Aspen-Pfizer court victory in Brazil may help other deals awaiting final CADE approval

By Rodrigo Russo ( August 15, 2019, 14:52 GMT | Comment) -- Aspen Pharmacare and Pfizer have won a court battle over the Brazilian competition authority's temporary ban on closing deals until the agency's quorum is restored, MLex has learned. The confidential decision could have an impact on other deals similarly affected by the ban. A federal judge ruled that the drugmakers only must wait eight more days for their deal to be granted final approval by the Administrative Council for Economic Defense, or CADE — and that the 15-day deadline clock for final approval should be restarted from the moment the clearance granted by the agency's investigatory unit was suspended.Aspen Pharmacare and Pfizer have won a court battle over the Brazilian competition authority's temporary ban on closing deals until the agency's quorum is restored, MLex has learned. The confidential decision could have an impact on other deals similarly affected by the ban....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login